Benitec Biopharma
BNTC
BNTC
72 hedge funds and large institutions have $427M invested in Benitec Biopharma in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.29% more ownership
Funds ownership: 88.21% → 93.5% (+5.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
72
Holding in Top 10
2
Calls
–
Puts
$1K
Top Buyers
| 1 | +$25.6M | |
| 2 | +$23.1M | |
| 3 | +$10.7M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$10.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$9.01M |
Top Sellers
| 1 | -$5.43M | |
| 2 | -$1.09M | |
| 3 | -$281K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$61.6K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$61.4K |
